Assetmark, Inc Lannett CO Inc Transaction History

Assetmark, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$6.36 - $10.05 $680 - $1,075	-107 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$8.49 - $12.81 $161 - $243	19 Added 21.59%	107 $1,000
Q3 2019 Nov 13, 2019	BUY	$5.58 - $14.47 $491 - $1,273	88 New	88 $1,000
Q1 2019 May 14, 2019	SELL	$5.35 - $9.82 $219 - $402	-41 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$3.43 - $6.19 $226 - $408	-66 Reduced 61.68%	41 $0
Q1 2018 May 16, 2018	BUY	$14.7 - $24.95 $323 - $548	22 Added 25.88%	107 $2,000
Q4 2017 Feb 13, 2018	SELL	$19.9 - $29.25 $3,999 - $5,879	-201 Reduced 70.28%	85 $2,000
Q3 2017 Nov 08, 2017	BUY	$15.1 - $19.25 $2,400 - $3,060	159 Added 125.2%	286 $5,000
Q2 2017 Aug 15, 2017	BUY	N/A	82 Added 182.22%	127 $3,000
Q1 2017 Sep 15, 2017	BUY	N/A	45	45 $1,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.